Biolight signs agreement with the Praktikertjänst Group

Biolight signs agreement with the Praktikertjänst Group On this day Biolight has entered into an agreement with the Praktikertjänst Group. It is very positive for Biolight to be able to gain rapid acceptance for its proven treatment methodology and in that way be able to speed up its market penetration in Sweden. The Praktikertjänst Group has a thorough purchasing procedure with strong requirements when it comes to clinical studies, ISO certification and CE approval. Ola Kroon, who is responsible for the agreement at the Praktikertjänst Group, comments: "We enter into co-operative contracts aimed at fixing commercial conditions for those products we feel have or will be demanded by our operations. We see the Biolight concept as an exciting one and look forward to working with the company." The Praktikertjänst Group is a co-operative venture operating in the nursing, school and health care areas. "This agreement provides us with entirely new opportunities to be able to present the methodology, as well as simplifying effective marketing efforts, " says Thomas Ericsson, business area manager at Biolight International AB. Christer Wallin, President of Biolight International AB adds: "We have invested our technology with more than 20 years experience with treatment using monochromatic light. We are extremely pleased that the Praktikertjänst Group places such a high value on our product. Because of their close relationship to the care sector, they are a superb partner." Facts about the Praktikertjänst Group: The Praktikertjänst Group is the largest health care provider in Sweden and is run as a producer co-operative. It is owned by around 2100 practising dentists, physicians, physical therapists, dental technicians, laboratory managers, psychoanalysts, therapists, midwives, nurses, dental hygienists and occupational therapists active at all of 2200 facilities from Kiruna in the far north to Ystad in southern Sweden. The turnover in the parent company Praktikertjänst AB is just over four thousand million SEK with almost 8 000 employees. By adding in the subsidiaries Proliva (nursing, school and health care), Praktikertjänst Närsjukvård (local health services), and other subsidiaries, the total turnover reaches app. 5.8 thousand million SEK with some 13 000 employees. Facts about Biolight International AB: Biolight is a Swedish medical technology company that has developed a unique product for the treatment of damaged cells. The patented product is based on a method that introduces monochromatic light of a specific wavelength, pulse frequency and time. The light provides energy to the cell, increases its activities and initiates healing. A cell without sufficient energy is unable to contribute properly to healing. The method speeds healing processes and supplements traditional treatment. It contributes to an improved quality of life and reduced treatment expenses. As it is not pharmaceutical, the treatment is non- pharmacological and is applied externally. It is simple, painless and without side effects. Currently Biolight is active in treatment of ulcerations, dental care and rehabilitation. Clinical studies using the same stringent design as for pharmaceutical products have demonstrated that Biolight methods reduce healing times significantly for both gingivitis and chronic ulceration. A phase III study regarding gingivitis has shown that patients treated with Biolight® have 87% greater reduction in their inflammation as compared to patients who have undergone traditional treatment. Biolight International AB is a medical technology company, offering its customers, including patients, nursing staffs and authorities, various products and services based on the company's patented method for the use of pulsating, monochromatic light. The company aims to improve the quality of life for the patients and reduce the time to healing and treatment costs significantly. Through systematically executed clinical trials, Biolight is gradually extending the scientific basis needed to guarantee the method a solid position in the health care field. During the past few years, Biolight has focused on a small number of indication areas grouped around wound healing. For further information, please visit Biolight's homepage www.biolight.se or contact Christer Wallin, President of Biolight International AB, on +46-(0)8-622 52 70. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2001/10/29/20011029BIT00200/bit0001.doc http://www.waymaker.net/bitonline/2001/10/29/20011029BIT00200/bit0001.pdf